SS
Sapna Srivastwa
About Sapna Srivastwa
Data last updated:
Sapna Srivastwa is a Director at Delius Pharmaceuticals Private Limited (since 2016), Director at Axton Asia Drugs Private Limited (since 2025) and Director at Ambrion Sterling Dominion Labs India Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Delius Pharmaceuticals Private Limited at ₹19.28 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Delius Pharmaceuticals Private Limited U24232DL2014PTC270434 | Director | 24 Apr 2016 | 2014 | ₹19.28 Cr (FY 2024) | Active |
 Axton Asia Drugs Private Limited U21001DL2025PTC460712 | Director | 29 Dec 2025 | 2025 | Active | |
| Ambrion Sterling Dominion Labs India Private Limited U21000DL2025PTC459723 | Director | 16 Dec 2025 | 2025 | Active |
Board colleagues of Sapna Srivastwa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Digvijay Kumar Shrivastawa | 06887068 | Delius Pharmaceuticals Private Limited | Director |
| Kunal Kumar | 11214341 | Delius Pharmaceuticals Private Limited | Director |
| Anmol Saxena | 11431803 | Axton Asia Drugs Private Limited , Ambrion Sterling Dominion Labs India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sapna Srivastwa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sapna Srivastwa
Sapna Srivastwa currently holds 3 directorships: Delius Pharmaceuticals Private Limited (Director, since 24 Apr 2016, revenue ₹19.28 Cr (FY 2024)); Axton Asia Drugs Private Limited (Director, since 29 Dec 2025); Ambrion Sterling Dominion Labs India Private Limited (Director, since 16 Dec 2025).
Sapna Srivastwa was first appointed on 24 Apr 2016 as Director at Delius Pharmaceuticals Private Limited. The most recent appointment on record is 29 Dec 2025 at Axton Asia Drugs Private Limited.
The current boards of Sapna Srivastwa's companies include Digvijay Kumar Shrivastawa (Delius Pharmaceuticals Private Limited), Kunal Kumar (Delius Pharmaceuticals Private Limited), Anmol Saxena (Axton Asia Drugs Private Limited).